|
Index of reports
> Cases resulting in disability (22)
> Cases with Thrombocytopenia (4)
Below is the selection of adverse event reports related to Sutent (Sunitinib) that includes cases resulting in disability where reactions include thrombocytopenia.
Adverse event in female receiving Sutent (Sunitinib)
Reported by a physician from Germany on 2007-10-06
Patient: female, weighing 56.0 kg (123.2 pounds)
Adverse reactions / side effects: Dyspnoea, Flatulence, Palmar-Plantar Erythrodysaesthesia Syndrome, Loss of Consciousness, Mucosal Inflammation, Dysgeusia, Gamma-Glutamyltransferase Increased, Diarrhoea, C-Reactive Protein Increased, Thrombocytopenia, Hypertension, Asthenia, Cardiovascular Disorder, Leukopenia, Epistaxis
Adverse event resulted in: disablity
Suspect drug(s):
Sutent (Sunitinib)
Other drugs received by patient: Beta Blocking Agents; Drug, Unspecified
Adverse event in male receiving Sutent (Sunitinib)
Reported by a physician from Switzerland on 2007-07-05
Patient: male, weighing 92.0 kg (202.4 pounds)
Adverse reactions / side effects: Hepatic Enzyme Abnormal, Abdominal Pain, Cholestasis, Hyperhidrosis, Malaise, Anorexia, Thrombocytopenia, Infection
Adverse event resulted in: disablity
Suspect drug(s):
Sutent (Sunitinib)
Other drugs received by patient: Zestril; Hygroton
Adverse event in 56 year old male receiving Sutent (Sunitinib)
Reported by a individual with unspecified qualification on 2007-04-16
Patient: 56 year old male
Adverse reactions / side effects: Confusional State, Nausea, Therapeutic Agent Toxicity, Somnolence, Anticonvulsant Drug Level Increased, Dizziness, Gait Disturbance, Neutropenia, Thrombocytopenia
Adverse event resulted in: disablity
Suspect drug(s):
Dilantin
Dosage: 300 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
MS Contin
Dosage: 20 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Sutent
Dosage: 50 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Adverse event in 56 year old male receiving Sutent (Sunitinib)
Reported by a individual with unspecified qualification on 2007-04-12
Patient: 56 year old male
Adverse reactions / side effects: Confusional State, Nausea, Therapeutic Agent Toxicity, Somnolence, Anticonvulsant Drug Level Increased, Dizziness, Gait Disturbance, Neutropenia, Thrombocytopenia
Adverse event resulted in: disablity
Suspect drug(s):
Dilantin
Dosage: 300 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
MS Contin
Dosage: 20 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Sutent
Dosage: 50 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
|
